Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 116
Filtrar
1.
PLoS One ; 19(2): e0297924, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38330002

RESUMEN

Acute haemorrhagic diarrhoea is a common complaint in dogs. In addition to causes like intestinal parasites, dietary indiscretion, intestinal foreign bodies, canine parvovirus infection, or hypoadrenocorticism, acute haemorrhagic diarrhoea syndrome (AHDS) is an important and sometimes life-threatening differential diagnosis. There is some evidence supporting the link between Clostridium perfringens toxins and AHDS. These toxins may be partially responsible for the epithelial cell injury, but the pathogenesis of AHDS is still not fully understood. Recent studies have suggested that severe damage to the intestinal mucosa and associated barrier dysfunction can trigger chronic gastrointestinal illnesses. Besides bloodwork and classical markers for AHDS such as protein loss and intestinal bacterial dysbiosis, we focused mainly on the plasma-proteome to identify systemic pathological alterations during this disease and searched for potential biomarkers to improve the diagnosis. To accomplish the goals, we used liquid chromatography-mass spectrometry. We compared the proteomic profiles of 20 dogs with AHDS to 20 age-, breed-, and sex-matched control dogs. All dogs were examined, and several blood work parameters were determined and compared, including plasma biochemistry and cell counts. We identified and quantified (relative quantification) 207 plasmatic proteins, from which dozens showed significantly altered levels in AHDS. Serpina3, Lipopolysaccharide-binding protein, several Ig-like domain-containing proteins, Glyceraldehyde-3-phosphate dehydrogenase and Serum amyloid A were more abundant in plasma from AHDS affected dogs. In contrast, other proteins such as Paraoxonase, Selenoprotein, Amine oxidases, and Apolipoprotein C-IV were significantly less abundant. Many of the identified and quantified proteins are known to be associated with inflammation. Other proteins like Serpina3 and RPLP1 have a relevant role in oncogenesis. Some proteins and their roles have not yet been described in dogs with diarrhoea. Our study opens new avenues that could contribute to the understanding of the aetiology and pathophysiology of AHDS.


Asunto(s)
Enfermedades de los Perros , Proteoma , Perros , Animales , Proteómica , Hemorragia Gastrointestinal/microbiología , Síndrome , Diarrea/microbiología , Enfermedades de los Perros/patología
2.
J Pediatr ; 237: 34-40.e1, 2021 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-34197890

RESUMEN

OBJECTIVE: To analyze the results of an enhanced laboratory-surveillance protocol for bloody diarrhea aimed at identifying children with Shiga toxin-producing Escherichia coli (STEC) infection early in the course of the disease toward the early identification and management of patients with hemolytic uremic syndrome (HUS). STUDY DESIGN: The study (2010-2019) involved a referral population of 2.3 million children. Stool samples of patients with bloody diarrhea were screened for Shiga toxin (Stx) genes. Positive patients were rehydrated and monitored for hemoglobinuria until diarrhea resolved or STEC-HUS was diagnosed. RESULTS: A total of 4767 children were screened; 214 (4.5%) were positive for either Stx1 (29.0%) or Stx2 (45.3%) or both Stx1+2 (25.7%); 34 patients (15.9%) developed STEC-HUS (0.71% of bloody diarrheas). Hemoglobinuria was present in all patients with HUS. Patients with Stx2 alone showed a greater risk of STEC-HUS (23.7% vs 12.7%) and none of the patients with Stx1 alone developed HUS. During the same period of time, 95 other patients were diagnosed STEC-HUS but were not captured by the screening program (26 had nonbloody diarrhea, 11 came from areas not covered by the screening program, and 58 had not been referred to the screening program, although they did meet the inclusion criteria). At HUS presentation, serum creatinine of patients identified by screening was significantly lower compared with that of the remaining patients (median 0.9 vs 1.51 mg/dL). CONCLUSIONS: Nearly 1% of children with bloody diarrhea developed STEC-HUS, and its diagnosis was anticipated by the screening program for Stx. The screening of bloody diarrhea for Stx is recommended, and monitoring patients carrying Stx2 with urine dipstick for hemoglobinuria is suggested to identify the renal complication as early as possible.


Asunto(s)
Diarrea/microbiología , Infecciones por Escherichia coli/diagnóstico , Hemorragia Gastrointestinal/microbiología , Síndrome Hemolítico-Urémico/microbiología , Tamizaje Masivo/métodos , Escherichia coli Shiga-Toxigénica/aislamiento & purificación , Adolescente , Niño , Preescolar , Diagnóstico Precoz , Infecciones por Escherichia coli/complicaciones , Femenino , Hemorragia Gastrointestinal/diagnóstico , Genes Bacterianos , Síndrome Hemolítico-Urémico/diagnóstico , Síndrome Hemolítico-Urémico/epidemiología , Síndrome Hemolítico-Urémico/terapia , Humanos , Lactante , Recién Nacido , Italia , Masculino , Toxinas Shiga/genética , Escherichia coli Shiga-Toxigénica/genética , Resultado del Tratamiento , Adulto Joven
3.
BMC Infect Dis ; 21(1): 376, 2021 Apr 21.
Artículo en Inglés | MEDLINE | ID: mdl-33882850

RESUMEN

BACKGROUND: The manifestation of Talaromyces marneffei infection in some HIV-infected patients may be atypical. Cases with gastrointestinal involvement have rarely been reported. It is hard to make a diagnosis when patients are lacking the characteristic rash and positive blood culture. CASE PRESENTATION: Here, we described a patient living with HIV who complained of fever and abdominal pain, and was rapidly diagnosed with Talaromyces marneffei infection by metagenomic next-generation sequencing (mNGS) using formalin-fixation and paraffin-embedded (FFPE) samples of omentum majus tissue. We also reviewed reported related cases. CONCLUSIONS: Talaromyces marneffei is an unusual cause of clinical presentations involving obvious abdominal pain and lower gastrointestinal bleeding, but can be included in the differential diagnosis. As an important diagnostic tool, the significance of mNGS using FFPE samples of lesions provides a more targeted diagnosis.


Asunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/complicaciones , Hemorragia Gastrointestinal/microbiología , VIH/genética , Secuenciación de Nucleótidos de Alto Rendimiento/métodos , Metagenómica/métodos , Micosis/complicaciones , Micosis/fisiopatología , Talaromyces/genética , Infecciones Oportunistas Relacionadas con el SIDA/tratamiento farmacológico , Infecciones Oportunistas Relacionadas con el SIDA/virología , Adulto , Fármacos Anti-VIH/uso terapéutico , Antifúngicos/uso terapéutico , China , Diagnóstico Diferencial , Estudios de Seguimiento , Humanos , Masculino , Micosis/tratamiento farmacológico , Micosis/microbiología , ARN Viral/sangre , Resultado del Tratamiento
5.
J Assoc Physicians India ; 67(4): 79-81, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-31299848

RESUMEN

Acute fulminant necrotizing amebic colitis rarely presents with massive lifethreatening lower gastrointestinal bleeding without diarrhea. Diagnosis is difficult as colonoscopy is suboptimal due to active bleeding, stool testing is often negative and a positive serology cannot confirm the diagnosis. We herein report a case of a 39-year-old male who presented with profuse bleeding per rectum, without associated significant antecedent history of fever or diarrhea. Colonoscopy was inconclusive as active bleeding obscured the vision. Computed tomography of abdomen revealed non-specific thickening of the caecum. Emergency laparotomy with right hemicolectomy and temporary ileostomy was performed. Microscopic examination of colonic mucosa revealed Entamoeba histolytica trophozoites with erythrophagocytosis suggestive of fulminant amebic colitis. Intravenous metronidazole was given subsequently and patient recovered completely. Ileocolonic anastomosis was done after closing the ileostomy three months later. This case highlights this exceedingly rare presentation of fulminant amebic colitis which poses a diagnostic challenge and can be life threatening without early surgical intervention.


Asunto(s)
Disentería Amebiana/diagnóstico , Hemorragia Gastrointestinal/diagnóstico , Adulto , Colon , Colonoscopía , Diarrea , Disentería Amebiana/terapia , Hemorragia Gastrointestinal/microbiología , Hemorragia Gastrointestinal/terapia , Humanos , Masculino
6.
BMC Res Notes ; 12(1): 278, 2019 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-31092295

RESUMEN

OBJECTIVE: Peptic ulcer disease is a condition in which an important role has infection with H. pylori. The most common complication of peptic ulcer is bleeding. The presence of H. pylori triggers local and systemic cytokine signaling which may affect processes such as healing, gastric or duodenal rupture, and carcinogenesis. In this study, we examined the concentrations of IL-1ß, IL-6, IL-10, TNF, TGF-ß and IL-17A in serum by enzyme immunoassay and their mRNA expressions in periulcer biopsies obtained from patients with bleeding peptic ulcer by means of real-time-PCR. RESULTS: We have shown that pro-inflammatory IL-6 and TNF concentrations in serum were significantly higher in patients who were infected with H. pylori, while the concentrations of TGF-ß and IL-17A were significantly lower compared to non-infected subjects. IL-17A expression in periulcer mucosa was significantly higher in patients who were infected with H. pylori, while the expression of other cytokines, there was no significant difference compared to non-infected controls. Considering higher serum concentrations in non-infected subjects and higher IL-17A expression in mucosal tissue of infected patients, our data support the studies that found IL-17A has protective role in eradication of H. pylori infection in infected patients.


Asunto(s)
Citocinas/genética , Úlcera Duodenal/microbiología , Hemorragia Gastrointestinal/microbiología , Regulación de la Expresión Génica , Infecciones por Helicobacter/microbiología , Helicobacter pylori/fisiología , Citocinas/sangre , Citocinas/metabolismo , Úlcera Duodenal/sangre , Úlcera Duodenal/complicaciones , Úlcera Duodenal/genética , Femenino , Mucosa Gástrica/microbiología , Mucosa Gástrica/patología , Hemorragia Gastrointestinal/sangre , Hemorragia Gastrointestinal/complicaciones , Hemorragia Gastrointestinal/genética , Infecciones por Helicobacter/sangre , Infecciones por Helicobacter/complicaciones , Infecciones por Helicobacter/genética , Humanos , Masculino , Persona de Mediana Edad , ARN Mensajero/genética , ARN Mensajero/metabolismo
7.
Nat Commun ; 10(1): 1826, 2019 04 23.
Artículo en Inglés | MEDLINE | ID: mdl-31015451

RESUMEN

The bacterial pathogen Shigella flexneri causes 270 million cases of bacillary dysentery (blood in stool) worldwide every year, resulting in more than 200,000 deaths. A major challenge in combating bacillary dysentery is the lack of a small-animal model that recapitulates the symptoms observed in infected individuals, including bloody diarrhea. Here, we show that similar to humans, infant rabbits infected with S. flexneri experience severe inflammation, massive ulceration of the colonic mucosa, and bloody diarrhea. T3SS-dependent invasion of epithelial cells is necessary and sufficient for mediating immune cell infiltration and vascular lesions. However, massive ulceration of the colonic mucosa, bloody diarrhea, and dramatic weight loss are strictly contingent on the ability of the bacteria to spread from cell to cell. The infant rabbit model features bacterial dissemination as a critical determinant of S. flexneri pathogenesis and provides a unique small-animal model for research and development of therapeutic interventions.


Asunto(s)
Diarrea/patología , Disentería Bacilar/patología , Hemorragia Gastrointestinal/patología , Shigella flexneri/patogenicidad , Sistemas de Secreción Tipo III/inmunología , Animales , Animales Recién Nacidos/microbiología , Colon/microbiología , Colon/patología , Diarrea/microbiología , Modelos Animales de Enfermedad , Disentería Bacilar/microbiología , Células Epiteliales/microbiología , Femenino , Hemorragia Gastrointestinal/microbiología , Células HT29 , Humanos , Mucosa Intestinal/microbiología , Mucosa Intestinal/patología , Embarazo , Conejos
8.
Eur J Gastroenterol Hepatol ; 31(5): 642-645, 2019 05.
Artículo en Inglés | MEDLINE | ID: mdl-30694911

RESUMEN

Whipple's disease is a rare, multisystem infection caused by the Gram-positive Tropheryma whippelii organism. In addition to neurological and rheumatological manifestations, this disease can result in significant gastrointestinal symptoms such as malabsorption, diarrhea, and weight loss. Given the diagnostic challenge and rare occurrence, a high index of suspicion is critical to prevent morbidity and mortality from this otherwise highly infectious disease transmitted via the fecal-oral route. We present a very rare but near-fatal case of hypovolemic shock secondary to protein-losing enteropathy and gastrointestinal bleeding from small bowel T. whippelii infection. Furthermore, the epidemiology, clinical presentation, diagnosis, and management of Whipple's disease is reviewed.


Asunto(s)
Hemorragia Gastrointestinal/microbiología , Enteropatías Perdedoras de Proteínas/microbiología , Choque/microbiología , Tropheryma/patogenicidad , Enfermedad de Whipple/microbiología , Antibacterianos/uso terapéutico , Biopsia , Diagnóstico Tardío , Progresión de la Enfermedad , Duodenoscopía , Hemorragia Gastrointestinal/diagnóstico , Hemorragia Gastrointestinal/tratamiento farmacológico , Humanos , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Enteropatías Perdedoras de Proteínas/diagnóstico , Enteropatías Perdedoras de Proteínas/tratamiento farmacológico , Choque/diagnóstico , Choque/tratamiento farmacológico , Tomografía Computarizada por Rayos X , Resultado del Tratamiento , Tropheryma/efectos de los fármacos , Vasoconstrictores/uso terapéutico , Enfermedad de Whipple/complicaciones , Enfermedad de Whipple/diagnóstico , Enfermedad de Whipple/tratamiento farmacológico
10.
Digestion ; 99(1): 66-71, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30554208

RESUMEN

BACKGROUND AND AIM: Helicobacter pylori infection is a primary cause of gastroduodenal ulcers. To investigate whether there is an association between H. pylori infection and small intestinal mucosal injury. METHODS: Patients were selected from a general pool of subjects who underwent capsule endoscopy for current or past obscure gastrointestinal bleeding. Characteristics including age, gender, history, treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) and/or acid suppressant, diagnosis, and H. pylori infection were investigated. Patients infected with H. pylori had positive test result, ranging 30 days before to 30 days after capsule endoscopy. Patients diagnosed with inflammatory diseases, malignant tumors, etc. were excluded. All video images were re-evaluated to count small intestinal mucosal breaks. Eligible patient variables were compared. RESULTS: A total of 92 patients (30 infected with H. pylori/62 uninfected) were eligible. By univariate analysis of the number of mucosal breaks, patients treated with NSAIDs were found to have more mucosal breaks than patients untreated (38%: 8/21 vs. 18%: 13/71; p = 0.004), and the possible association was detected between patients infected with H. pylori and those who were not (67%: 14/21 vs. 37%: 26/71; p = 0.081). When comparing the H. pylori infected and uninfected patients, the rate of patients with mucosal breaks was greater in infected patients (47%: 14/30 vs. 11%: 7/62; p = 0.001). After excluding patients treated with NSAIDs, the number of mucosal breaks was also greater in patients infected with H. pylori (1.2 ± 1.5 vs. 0.38 ± 0.62; p = 0.001). CONCLUSION: There is a possibility that H. pylori infection induces small intestinal mucosal injury.


Asunto(s)
Infecciones por Helicobacter/complicaciones , Helicobacter pylori , Enfermedades Intestinales/microbiología , Úlcera Péptica/microbiología , Antiinflamatorios no Esteroideos/efectos adversos , Endoscopía Capsular , Femenino , Hemorragia Gastrointestinal/diagnóstico , Hemorragia Gastrointestinal/microbiología , Infecciones por Helicobacter/tratamiento farmacológico , Infecciones por Helicobacter/microbiología , Humanos , Enfermedades Intestinales/inducido químicamente , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/microbiología , Intestino Delgado/efectos de los fármacos , Intestino Delgado/microbiología , Masculino , Persona de Mediana Edad , Úlcera Péptica/inducido químicamente , Proyectos Piloto , Estudios Retrospectivos
11.
Tunis Med ; 96(2): 142-147, 2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30324980

RESUMEN

INTRODUCTION: Acute esophageal necrosis, also known as black esophagus, is a rare digestive complication, frequently manifested by an upper gastrointestinal hemorrhage and occurs in patients with comorbidities. AIM: To report the case of a patient with a black esophagus revealed by an upper gastrointestinal hemorrhage. OBSERVATION: A 72-year-old patient with a history of diabetes mellitus, hypertension and ischemic heart disease was hospitalized in surgical intensive care unit for hemorrhagic shock induced by cholecystectomy. On the 7th postoperative day, the patient developed acute hematemesis. Gastroscopy showed circumferential necrosis, localized in the middle and lower third of the esophagus and stopped abruptly at the gastroesophageal junction. Gastric mucosa was strictly normal. The bulb and the first part of duodenum showed multiple superficial ulcers without signs of recent hemorrhage. The patient was placed on absolute diet and total parenteral nutrition associated with high-dose intravenous proton pump inhibitor. Second-look gastroscopy, performed six days later, showed a significant improvement in esophageal lesions. The evolution was marked by the occurrence of pneumonia complicated by septic shock which caused patient's death. CONCLUSION: Black esophagus is a rare pathology of multifactorial etiology. Treatment is based on proton pump inhibitors in combination with resuscitation measures to control comorbidities. Mortality remains high due to the seriousness of comorbid disease states often associated with this condition.


Asunto(s)
Esofagitis/diagnóstico , Esófago/patología , Anciano , Candidiasis Bucal/complicaciones , Candidiasis Bucal/diagnóstico , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/microbiología , Esofagitis/microbiología , Esófago/microbiología , Resultado Fatal , Femenino , Hemorragia Gastrointestinal/complicaciones , Hemorragia Gastrointestinal/diagnóstico , Hemorragia Gastrointestinal/microbiología , Hematemesis/diagnóstico , Hematemesis/microbiología , Humanos , Necrosis/diagnóstico , Necrosis/microbiología , Pigmentación , Infecciones por Pseudomonas/complicaciones , Infecciones por Pseudomonas/diagnóstico , Pseudomonas aeruginosa/aislamiento & purificación , Choque Séptico/complicaciones , Choque Séptico/diagnóstico
12.
J Neonatal Perinatal Med ; 11(3): 335-338, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30010146

RESUMEN

Neonatal adenovirus infection is infrequent, but in most cases the outcome of the infection is fatal. In this case report we describe the hospital course of a 3 day old newborn patient presenting with bloody stools and thrombocytopenia that remained clinically stable and had a benign course following Adenovirus 40/41 infection detected in stool. Neonatal adenovirus infection should be considered in the differential diagnosis of neonatal sepsis and pneumonia but also in patients that present with hematochezia, thrombocytopenia and/or other less specific signs and symptoms of viral illness.


Asunto(s)
Infecciones por Adenoviridae/congénito , Ampicilina/uso terapéutico , Antibacterianos/uso terapéutico , Hemorragia Gastrointestinal/microbiología , Gentamicinas/uso terapéutico , Trombocitopenia/microbiología , Infecciones por Adenoviridae/tratamiento farmacológico , Infecciones por Adenoviridae/microbiología , Femenino , Hemorragia Gastrointestinal/tratamiento farmacológico , Humanos , Recién Nacido , Embarazo , Trombocitopenia/tratamiento farmacológico , Resultado del Tratamiento
13.
Int J Surg Pathol ; 25(7): 592-598, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28530163

RESUMEN

Histoplasmosis is an invasive mycosis caused by inhalation of the spores of dimorphic fungi Histoplasma capsulatum. The disease manifests in the lung as acute or chronic pulmonary histoplasmosis and in severe cases gets disseminated in multiple organs like skin, adrenal gland, central nervous system, lymph node, liver, spleen, bone marrow, and gastrointestinal tract. It occurs most commonly in immunodeficient patients like HIV-positive patients and transplant recipients, while immunocompetent hosts are affected rarely. In cases of gastrointestinal histoplasmosis, the samples are collected for culture and biopsy should be sent for histopathological examination for definitive diagnosis. We conducted a retrospective study of colonic biopsies performed in the department of gastroenterology in a tertiary care hospital of north India from January 2014 to December 2015. Five cases of colonic histoplasmosis were diagnosed on histopathology out of which 4 patients were from north India while 1 patient was from Myanmar. The patients presented with various complaints, including loose stools, diarrhea, altered bowel habits, and gastrointestinal bleeding. The prognosis is very good after early and aggressive treatment while the disease is fatal if it remains untreated. In our study, 2 patients died within few days of diagnosis due to delay in the diagnosis, dissemination, and associated complications. Other patients were started on amphotericin B deoxycholate and are under follow-up. An early diagnosis of gastrointestinal histoplasmosis is important as appropriate treatment leads to long-term survival while untreated cases are almost fatal.


Asunto(s)
Antifúngicos/uso terapéutico , Colon/patología , Diarrea/patología , Hemorragia Gastrointestinal/patología , Histoplasmosis/patología , Adulto , Anciano , Anfotericina B/uso terapéutico , Biopsia , Colonoscopía , Ácido Desoxicólico/uso terapéutico , Diarrea/tratamiento farmacológico , Diarrea/microbiología , Diarrea/mortalidad , Combinación de Medicamentos , Femenino , Estudios de Seguimiento , Hemorragia Gastrointestinal/tratamiento farmacológico , Hemorragia Gastrointestinal/microbiología , Hemorragia Gastrointestinal/mortalidad , Histoplasma/aislamiento & purificación , Histoplasmosis/tratamiento farmacológico , Histoplasmosis/microbiología , Histoplasmosis/mortalidad , Humanos , India , Masculino , Persona de Mediana Edad , Pronóstico , Estudios Retrospectivos , Factores de Tiempo
14.
Rev. gastroenterol. Perú ; 37(1): 96-99, ene.-mar. 2017. ilus
Artículo en Español | LILACS | ID: biblio-991233

RESUMEN

La leptospirosis es una enfermedad causada por la espiroqueta Leptospira. Se trata de una zoonosis de distribución mundial, con predominio en los trópicos. En España no es frecuente pero sí se observan casos en zonas más húmedas o con presencia de ríos, lagos o estanques, como son Cataluña, Andalucía o la Comunidad Valenciana, donde se relaciona con los arrozales. Los transmisores son múltiples animales como vacas o ratas, contagiándose el ser humano mediante contacto directo con estos animales o su orina, o bien de forma indirecta al consumir o estar en contacto con agua contaminada por la orina de éstos. Las manifestaciones clínicas son muy variables, siendo asintomática o poco sintomática en la mayoría de los pacientes. Aunque no ocurre siempre, la leptospirosis cursa con una primera fase con fiebre, mialgias, afectación renal o hemorragia de distintos órganos, seguida de una segunda fase con presencia de ictericia por afectación hepática. La enfermedad de Weil es una forma de leptospirosis grave caracterizada por afectación hepática con ictericia e insuficiencia renal aguda, asociada a una considerable mortalidad. El diagnóstico se basa en técnicas serológicas y detección de DNA mediante PCR. El tratamiento consta de medidas de soporte y antibioticoterapia. Presentamos un paciente con enfermedad de Weil y hemorragia digestiva por leptospirosis, con una evolución clínica fulminante, y hacemos hincapié en la necesidad de tener presente esta entidad, especialmente en ambientes epidemiológicos favorables como el de este paciente, con el fin de lograr un diagnóstico precoz.


Leptospirosis disease is caused by the spirochete Leptospira. It is a worldwide distribution zoonosis, with predominance in the tropics. In Spain, it is not frequent but some cases have been noticed especially in humid areas surrounded by rivers, lakes or ponds, such as Catalonia, Andalucia or the Valencian Community. It is transmitted by a variety of animals such as cows or rats, that are infected either by direct contact with these animals or their urine, or indirectly by consuming or being in contact with water contaminated by their urine. The clinical manifestations are very variable, being asymptomatic or not very symptomatic in most of the patients. Unusually, leptospirosis presents with a first phase with fever, myalgias, liver injury or different organs hemorrhage, followed by a second phase with the presence of jaundice due to hepatic failure. Weil's disease is a kind of severe leptospirosis characterized by hepatic failure with jaundice and acute renal failure, associated with high mortality rates. The diagnosis is based on serological techniques and DNA detection by PCR. The treatment consists of life support measures and antibiotic therapy. A patient with Weil's disease and leptospirosis digestive bleeding is presented, with a fulminant clinical course. In order to achieve an early diagnosis, the need to keep this entity in mind must be emphasized, especially in favorable epidemiological environments as the one of this patient.


Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Enfermedad de Weil/diagnóstico , Fallo Hepático Agudo/microbiología , Hemorragia Gastrointestinal/microbiología , Enfermedad de Weil/complicaciones , Fallo Hepático Agudo/diagnóstico , Resultado Fatal , Hemorragia Gastrointestinal/diagnóstico
16.
Anaerobe ; 42: 31-32, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27377777

RESUMEN

Clostridium difficile infection (CDI) is increasing in incidence and severity. Clinically, diarrhea frequently occurs, but severe hematochezia is rarely seen with CDI. We describe here a hematopoietic stem cell transplantation (HSCT) recipient who experienced life-threatening gastrointestinal bleeding due to severe CDI. Subsequent stool surveillance and molecular typing observed the patient who had two episodes of recurrence with a new strain of C. difficile distinct from the initial infection. We analyze C. difficile strains obtained from the patient, and also discuss the diagnosis and treatment of this case.


Asunto(s)
Clostridioides difficile/aislamiento & purificación , Infecciones por Clostridium/inmunología , Diarrea/inmunología , Hemorragia Gastrointestinal/inmunología , Huésped Inmunocomprometido , Clostridioides difficile/genética , Infecciones por Clostridium/diagnóstico , Infecciones por Clostridium/microbiología , Diarrea/diagnóstico , Diarrea/microbiología , Heces/microbiología , Hemorragia Gastrointestinal/diagnóstico , Hemorragia Gastrointestinal/microbiología , Trasplante de Células Madre Hematopoyéticas , Humanos , Masculino , Leucemia-Linfoma Linfoblástico de Células Precursoras/inmunología , Leucemia-Linfoma Linfoblástico de Células Precursoras/patología , Leucemia-Linfoma Linfoblástico de Células Precursoras/terapia , Recurrencia , Adulto Joven
17.
BMC Infect Dis ; 16: 252, 2016 06 07.
Artículo en Inglés | MEDLINE | ID: mdl-27267044

RESUMEN

BACKGROUND: Enterobacter species are important nosocomial pathogens, and there is growing concern about their ability to develop resistance during antimicrobial therapy. However, few data are available on the clinical characteristics and outcomes of Enterobacter spontaneous bacterial peritonitis (SBP). METHODS: We retrospectively identified all patients with SBP caused by Enterobacter species admitted to a tertiary care hospital between January 1997 and December 2013. Each case was age- and sex-matched with four patients with Escherichia coli SBP. RESULTS: A total of 32 cases with Enterobacter SBP and 128 controls with E. coli SBP were included. Twenty-one (65.6 %) cases and 111 (86.7 %) controls had Child-Pugh class C (P = 0.006). Cases were significantly more likely to have hepatocellular carcinoma (65.6 % vs. 37.5 %, P = 0.004) and upper gastrointestinal bleeding (28.1 % vs. 9.4 %, P = 0.005). The initial response to empirical therapy (81.3 % vs. 81.2 %, P = 0.995) and the 30-day mortality (37.5 % vs. 28.9 %, P = 0.35) were not significantly different between the groups. Drug resistance emerged in one case and in no controls (4.3 % [1/23] vs. 0 % [0/98], P = 0.19). CONCLUSIONS: Compared with E. coli SBP, patients with Enterobacter SBP more frequently had hepatocellular carcinoma and upper gastrointestinal bleeding, yet clinical outcomes were comparable. Development of resistance during third-generation cephalosporin therapy was infrequent in patients with Enterobacter SBP.


Asunto(s)
Infecciones por Enterobacteriaceae/microbiología , Escherichia/aislamiento & purificación , Cirrosis Hepática/microbiología , Peritonitis/microbiología , Adolescente , Adulto , Anciano , Estudios de Casos y Controles , Infecciones por Enterobacteriaceae/tratamiento farmacológico , Infecciones por Enterobacteriaceae/epidemiología , Escherichia/clasificación , Escherichia/patogenicidad , Escherichia coli/clasificación , Escherichia coli/aislamiento & purificación , Escherichia coli/patogenicidad , Femenino , Hemorragia Gastrointestinal/epidemiología , Hemorragia Gastrointestinal/microbiología , Humanos , Cirrosis Hepática/tratamiento farmacológico , Cirrosis Hepática/epidemiología , Masculino , Persona de Mediana Edad , Peritonitis/tratamiento farmacológico , Peritonitis/epidemiología , República de Corea/epidemiología , Estudios Retrospectivos , Adulto Joven
18.
J Med Case Rep ; 10: 6, 2016 Jan 19.
Artículo en Inglés | MEDLINE | ID: mdl-26781434

RESUMEN

INTRODUCTION: Massive gastrointestinal bleeding is an emergency that can sometimes require immediate surgery. We report the first case, to the best of our knowledge, of massive rectal bleeding due to Yersinia enterocolitica, requiring ileocecal resection. CASE PRESENTATION: A 41-year-old North African woman was admitted to our emergency department for massive rectal bleeding. She had a history of an iron deficiency anemia of unknown cause, and diarrhea 2 months before the admission. On admission to our emergency unit, she was in a state of hemodynamic collapse. An examination showed discolored conjunctivas, massive rectal bleeding with clots and no abdominal pain. The first medical treatment included the use of noradrenaline. An upper gastrointestinal endoscopy was performed and did not show any lesions. Computed tomography of her abdomen showed significant and hypervascular wall thickening of her terminal ileum suggestive of a tumor. Because her massive rectal bleeding worsened and her collapse persisted, an exploratory laparotomy and ileocecal resection were immediately performed on the patient. Histopathological analysis showed enteritis caused by Yersinia enterocolitica. Her outcome was favorable. CONCLUSION: Enteritis due to Yersinia enterocolitica can take a pseudotumoral form and mislead the diagnosis of gastrointestinal bleeding.


Asunto(s)
Antibacterianos/uso terapéutico , Ciego/cirugía , Fluoroquinolonas/uso terapéutico , Hemorragia Gastrointestinal/microbiología , Íleon/cirugía , Laparotomía , Yersiniosis/complicaciones , Yersinia enterocolitica/aislamiento & purificación , Adulto , Anemia Ferropénica/etiología , Diarrea/microbiología , Servicios Médicos de Urgencia , Femenino , Hemorragia Gastrointestinal/tratamiento farmacológico , Humanos , Hierro/uso terapéutico , Tomografía Computarizada por Rayos X , Oligoelementos/uso terapéutico , Resultado del Tratamiento , Yersiniosis/tratamiento farmacológico , Yersiniosis/microbiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA